Cytoreduction and hyper-thermic intraperitoneal chemotherapy versus cytoreduction only for stage II & III ovarian cancer / Mohamed Ibrahim Ibrahim Fahim ; Supervised Omaiya Abdelhamid Nassar , Osman Mohamed Mansour , Abdelmaksoud Mohamed Abdelmaksoud
Material type:
- مقارنه استئصال الورم والحقن الكيماوى الساخن داخل البطن مع استئصال الورم فقط لاورام المبيض الخبيثه الدرجه الثانيه والثالثه [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.Ph.D.2018.Mo.C (Browse shelf(Opens below)) | Not for loan | 01010110077288000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.Ph.D.2018.Mo.C (Browse shelf(Opens below)) | 77288.CD | Not for loan | 01020110077288000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology (Surgical)
Background: Treatment bycytoreductive surgery (CRS) and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has been an option for selected patients with peritoneal carcinomatosis.This study aims to evaluate the impact of HIPEC in primary and recurrent epithelial ovarian cancer and explore the main significant prognostic factors in epithelial ovarian cancer. Patients and Methods: A prospective, non-randomized, mono-centric clinical trial including 48 epithelial ovarian cancer patients treated and followed up between 2012 and 2016. They were treated by complete cytoreduction with/without HIPEC for primary cases and complete cytoreduction with HIPEC for recurrent cases.The study was performed at National Cancer Institute (NCI)- Cairo University
Issued also as CD
There are no comments on this title.